Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International Conference
WARREN, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced a poster presentation at the upcoming American Thoracis Society (ATS) 2022 International Conference, being held May 13-18, 2022, in San Francisco, CA.
The ePoster will be released on the day of presenation, will be available in the ePoster Viewing Site and accessible to conference attendees. Additional details can be found at the ATS 2022 website.
SOC as a Service â€“ The Next Level of Managed Security
Digital Transformation Reengineering Process Production
Session Details TBA